🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are thrilled to help kick off the first #SeattleTechWeek. After seeing the huge successes in SF & LA, we thought, why not have one in Seattle? Sign up to attend: lu.ma/SEATTLE-TECHWE… Join us @ the Kickoff Bash! lu.ma/1hxwnbui Host an event: docs.google.com/forms/d/e/1FAI…

The #HUPOECR is hosting its next free online panel discussion! Join us on August 9th, 9AM CET to discuss the translation of science from benchtop to biotech, with panelists Jarrod Sandow (Jarrod Sandow) and Ruedi Aebersold. Register now at: shorturl.at/hvyNU ⭐️👀

Listening to #TheProteomicsShow and cracking up on the plane. @neely615 and @ProteomicsNews: "Normally at this point we go into other sections, but we went deep on that, so..." @JohnRYatesIII : "You can edit!" The Bens: "oh yeah no we don't edit."

My twitter feed is full of people supporting Data Colada against a $25 million dollar lawsuit from Francesca Gino when they blew the whistle on her data fraud. At the exact same time Harvard Business Review is promoting an article from Gino about how “speaking up” is dangerous!

A reminder that we are open for 2 more weeks, until the 31st of August. Apply at impetusgrants.org/apply

Common mistake of first time founders. They're often default secretive about what they're working on or what their plans are for fear of being copied. It's typically best to share what you're working on and what your plans are because it optimizes for serendipity.

UMAP and t-SNE are widely used in single-cell genomics to identifying features of interest, and visually explore data. In a new paper w/ Tara Chari we find that extensive distortions and inconsistent practices make such embeddings counter-productive.🧵journals.plos.org/ploscompbiol/a… 1/

In case folks are curious, reviewers kept asking us to discuss cost when we published on our nf-encyclopedia pipeline. Checkout the SI if curious: pubs.acs.org/doi/10.1021/ac… The tl;dr - it typically costs us <$0.10 USD per DIA sample, for both nf-encyclopedia and QuantMS 😉

I’m so proud of our team at Talus Bio. This new funding will help us dive into two additional indications and push our covalent chemistry approaches forward. Excited to be applying #TeamMassSpec #proteomics to curing diseases!

YC S21's @TalusBio combines automated cell processing, next-gen proteomics & advanced analytics to measure a drug's effect on the entire regulome. They just received $4.3M in funding to advance treatments for previously "undruggable" transcription factors geekwire.com/2023/talus-bio…

Do you (or one of your trainees) use Skyline Project for proteomics mass spectrometry research and want to teach others? I'm organizing a virtual Skyline workshop and looking for new instructors to get involved, especially trainees and early career researchers.

“There is a lack of appreciation of the intricacies of analytical science by other disciplines (especially chemists) who see it as little more than an exercise in measurement using commercial instrumentation." - R. Graham Cooks (R. Graham Cooks) 👏🏼 brnw.ch/21wBY0s

CS/ML people venturing into biology frequently assume that the data they're given is clean and that all the upstream processing steps have been figured out. This is absolutely not the case. I would encourage CS/ML people to really look into the gritty details like this.

Congratulations to Dr. Stan Fields on his retirement from the University of Washington! 🥳 With our new IPA, called Y2H, we celebrate his contributions to our understanding of biology!

"Although many methods exist for imputing missing values in proteomics data, in practice, the most commonly used methods are among the worst performing." Unfortunate, but true. biorxiv.org/content/10.110…

Our latest grant funding fuels the discovery of transformative treatments for #cancer, & beyond. Talus Bio CEO & Co-founder Alex Federation caught up w/ @RickPSBJ to dig into our vision for growth over the next months & yrs: bizjournals.com/seattle/news/2… #seattlestartup #lifescience

Transcription factor (TF) drugs have massive potential to treat diseases like #cancer—yet only a handful of TFs have approved drugs today. Why? 1 key barrier is that we haven't had the technology necessary to discover drugs for these challenging targets. Until now 👇

Garbage in, garbage out 🚮 Unpopular take in this post-ChatGPT era but the fanciest AI/ML model is still only as good as the data it's trained on 💁‍♀️

Only a few more weeks to submit your nominations for the 2024 US HUPO Association Awards! Nominations are due on Monday, October 16.

Lindsay K Pino - @[email protected] Sam Payne @JohnRYatesIII @mjmaccoss US HUPO Yes CSR is separated from NIH PO to eliminate any undue influence in review. For the early career reviewer program, see it here public.csr.nih.gov/ForReviewers/B…